Sandoz UK & Ireland

What Sandoz UK & Ireland does

Sandoz UK & Ireland is the regional operating entity through which the Sandoz generics pharmaceutical franchise is conducted in the United Kingdom and Ireland. The entity trades under the name Sandoz UK and is identified in the available source material as a division of the broader Sandoz organization, which in turn is described in the source as a division of Novartis. The operative URL is https://www.sandoz.com/uk-en/. Markets served include the United Kingdom (GBR) and, by inference from the entity's name, Ireland.

The company's specific product portfolio, customer base, pricing, and go-to-market mechanics are not disclosed in the available source data. No product listings, technology stack details, customer references, manufacturing footprint, or operational metrics were provided in the aggregated material. The only resolvable source consists of a homepage title, the trading name "Sandoz UK," and the geographic market identification "GBR," with no substantive descriptive content.

Revenue, headcount, funding history, leadership team, partnership portfolio, regulatory actions, mergers and acquisitions, and strategic transaction history are also not documented in the provided source data. As a result, granular analysis of the entity's scale, financial performance, customer concentration, and competitive positioning within the UK and Irish generic pharmaceutical markets is not possible from this source set alone.

Name

Sandoz UK & Ireland

Website

https://sandoz.uk.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Sandoz UK & Ireland serves as the United Kingdom and Ireland regional operating entity of Sandoz, the global generics pharmaceutical franchise. The entity markets generic medicines to healthcare providers, wholesalers, and patients across these two markets.

Ownership category

akta.pro rank

GTM type

B2B

Offering type

Hardware or Manufacturing

Core offering

Sandoz UK operates as the United Kingdom regional presence of Sandoz, evidenced by its homepage at sandoz.com/uk-en/ under the trading name "Sandoz UK". The provided source data does not include specific product, service, or portfolio details for this regional operation beyond its existence and UK market presence.

Product overview

No product details were available in the source data provided. The source content contained only the company name and homepage URL without any product listings, descriptions, or portfolio information.

Differentiator

Problem solved

Functional benefit

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Accord Healthcare: UK-headquartered generic pharmaceuticals company (part of Intas). Directly comparable as a UK-focused generics supplier competing for NHS contracts in the same therapeutic categories as Sandoz UK.
• Teva Pharmaceutical Industries: One of the world's largest generic pharmaceutical manufacturers with a major UK presence. Directly comparable to Sandoz UK & Ireland as both supply generic and biosimilar medicines into UK NHS and pharmacy channels.
• Aurobindo Pharma: Indian-headquartered global generics manufacturer with substantial UK business. Comparable as a cost-competitive generics supplier into UK pharmacy and NHS channels.
• Krka: Slovenia-headquartered generic pharmaceutical manufacturer with strong European footprint including UK. Directly competes with Sandoz on prescription generic supply.
• STADA Arzneimittel: European-focused generics and consumer healthcare company with UK distribution. Competes with Sandoz on generic molecules and biosimilars across European markets including the UK.
• Viatris: Global generics and biosimilars company (formed via Mylan-Pfizer Upjohn merger) with active UK operations. Competes head-to-head with Sandoz across generic molecules and NHS tender opportunities.
• Almus (part of Almus Pharmaceuticals): UK-focused generic medicines brand specifically targeting retail pharmacy channel. Comparable to Sandoz UK in product portfolio and channel focus, though operating at smaller scale.
• Zentiva Group: European generic pharmaceuticals manufacturer serving UK markets with a broad generics portfolio. Comparable in scale, business model, and target channels to Sandoz UK & Ireland.

Broad incumbents

• Sandoz Group AG: The Swiss-listed global parent organization (spun off from Novartis in 2023) of which Sandoz UK & Ireland is a regional subsidiary. Provides product, R&D, and capital backing to the UK/Ireland entity.

Regional players

• Rowa Pharmaceuticals: Ireland-based pharmaceutical manufacturer and generics supplier. Regionally relevant comparable to the Ireland-facing portion of Sandoz UK & Ireland's operations.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks4 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/sandoz-uk

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sandoz UK & Ireland